Zomedica Acquires Assisi’s Assets and Provide Drug-Free Solution for Treating Pain
Shots:
- Zomedica acquires Assisi’s assets & offers an additional drug-free solution to improve Zomedica pets' ability for treating pain, inflammation, anxiety, or behavioral disorders. Assisi has developed a cutting-edge line of tPEMFTM devices for companion animals that offer a safe, drug-free alternative for treating pain, inflammation, anxiety, or behavioral issues
- Clinical research has been done at Assisi on the use of tPEMF technology for treating pain, promoting healing, and reducing anxiety in companion animals
- The acquisition will expand Zomedica's product portfolio and continue to deliver solutions that enhance companion animal care while enhancing practice effectiveness and economic viability
Ref: Accesswire | Image: Assisi
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
